Balasa Dinverno & Foltz’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$217K Buy
2,079
+3
+0.1% +$329 0.01% 316
2022
Q2
$218K Sell
2,076
-240
-10% -$28.5K 0.01% 317
2022
Q1
$296K Sell
2,316
-90
-4% -$10.8K 0.02% 271
2021
Q4
$297K Hold
2,406
0.02% 276
2021
Q3
$342K Sell
2,406
-3
-0.1% -$441 0.02% 237
2021
Q2
$376K Buy
2,409
+77
+3% +$12.5K 0.03% 231
2021
Q1
$362K Buy
2,332
+3
+0.1% +$465 0.03% 215
2020
Q4
$348K Buy
2,329
+148
+7% +$20.9K 0.03% 207
2020
Q3
$288K Hold
2,181
0.03% 210
2020
Q2
$253K Sell
2,181
-247
-10% -$28.5K 0.03% 194
2020
Q1
$238K Buy
2,428
+199
+9% +$26.1K 0.03% 215
2019
Q4
$324K Buy
2,229
+93
+4% +$12.8K 0.03% 204
2019
Q3
$285K Sell
2,136
-93
-4% -$12K 0.03% 195
2019
Q2
$255K Buy
2,229
+18
+0.8% +$2.11K 0.03% 205
2019
Q1
$274K Sell
2,211
-29
-1% -$3.3K 0.03% 200
2018
Q4
$226K Buy
+2,240
New +$252K 0.03% 200

Other funds holding ZBH

Balasa Dinverno & Foltz's ZBH Position: Q3 2022 in Review

Balasa Dinverno & Foltz increased its Zimmer Biomet (ZBH) stake by 0.14% in Q3 2022, buying an estimated $329 and bringing the position to 2,079 shares worth $217K. The position accounts for 0.01% of the portfolio, ranked #316.

Balasa Dinverno & Foltz first reported a position in ZBH in Q4 2018 and has held it in 16 quarters since. The position peaked at $376K in Q2 2021. 919 funds tracked by Wall St. Rank hold ZBH as of Q3 2022.

  • Balasa Dinverno & Foltz held 2,079 shares of Zimmer Biomet worth $217K as of Q3 2022.
  • Balasa Dinverno & Foltz bought 3 Zimmer Biomet shares in Q3 2022, an estimated $329.
  • Zimmer Biomet made up 0.01% of Balasa Dinverno & Foltz's portfolio in Q3 2022, its #316 holding.
  • Balasa Dinverno & Foltz first reported a position in Zimmer Biomet in Q4 2018 and has held it in 16 quarters since.
  • Balasa Dinverno & Foltz's Zimmer Biomet position peaked at $376K in Q2 2021.
  • 919 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2022.

Based on Balasa Dinverno & Foltz's 13F filing for Q3 2022, filed 25 Oct 2022.